Although recently it has been reported that miR-216b could inhibit cell growth by targeting FOXM1 in hepatocellular carcinoma and melanoma [38, 39], the role of miR-216b and the relationship between miR-216b and FOXM1 in cervical cancer remains unclear. This evidence concerns the gene FOXM1 and melanoma.